Study S001666

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03498001
Acronym: LICAS-MR
Study type: INTERVENTIONAL
Masking: NONE
Status: COMPLETED
Enrollment: 42
Start: 2018-04-16
Primary completion: 2023-06-06
Lead sponsor: Centre Hospitalier Universitaire Dijon
Conditions: Type II Diabetes
Interventions: DRUG:GLP-1 agonists; PROCEDURE:Cardiac MRI; OTHER:Follow up by phone
Results posted: FALSE

Registered primary outcomes

Change from Baseline Concentration of intramyocardial triglycerides at 6 months [Month 6]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0008097	Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study. Houbachi L, Diabetes research and clinical practice	2025	Nonrandomized study	PMID 39900263 DOI	registry reference RESULT:39900263